CVS Health (CVS) to Release Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS) will be issuing its quarterly earnings data before the market opens on Wednesday, May 1st. Analysts expect the company to announce earnings of $1.69 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same period last year, the business posted $1.99 EPS. The business’s revenue was up 11.9% compared to the same quarter last year. On average, analysts expect CVS Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

CVS Health Stock Performance

Shares of CVS Health stock opened at $68.50 on Wednesday. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The business has a 50-day moving average price of $74.97 and a two-hundred day moving average price of $73.76. CVS Health has a 1-year low of $64.41 and a 1-year high of $83.25. The company has a market cap of $86.34 billion, a P/E ratio of 10.60, a PEG ratio of 0.92 and a beta of 0.52.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.88%. CVS Health’s payout ratio is currently 41.18%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CVS shares. Piper Sandler increased their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research note on Wednesday, April 10th. Finally, Royal Bank of Canada reduced their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $89.44.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.24% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.